Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation.
<h4>Background</h4>The 3-hydroxy-3-methylglutaryl CoA reductase inhibitors (also called statins) exert proven beneficial effects on cardiovascular diseases. Recent data suggest a protective role for Transforming Growth Factor-beta (TGF-beta) in atherosclerosis by regulating the balance b...
Main Authors: | Juan Rodríguez-Vita, Eva Sánchez-Galán, Beatriz Santamaría, Elsa Sánchez-López, Raquel Rodrigues-Díez, Luís Miguel Blanco-Colio, Jesús Egido, Alberto Ortiz, Marta Ruiz-Ortega |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19088845/?tool=EBI |
Similar Items
-
Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process.
by: Raúl Rodrigues Díez, et al.
Published: (2010-01-01) -
TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2
by: Raquel Rodrigues-Díez, et al.
Published: (2015-01-01) -
Dissection of TGF-beta/Smads in the renal inflammation and fibrosis.
Published: (2012) -
Tgf-beta induced Erk phosphorylation of smad linker region regulates smad signaling.
by: Chris Hough, et al.
Published: (2012-01-01) -
Mechanoregulation of chondrocytes and chondroprogenitors: the role of TGF-BETA and SMAD signaling
by: Mouw, Janna Kay
Published: (2006)